No Script

Please Wait...

Al-Ahed Telegram

The Long Covid Phenomenon: ONE-THIRD of England’s Survivors Re-hospitalized, 12 % Died 

The Long Covid Phenomenon: ONE-THIRD of England’s Survivors Re-hospitalized, 12 % Died 
folder_openUnited Kingdom access_time2 months ago
starAdd to favorites

By Staff, Agencies

In an attempt to shed lifght on the “long Covid” phenomenon, a new study has found that aound 30 percent of those hospitalized with the coronavirus in England were readmitted for treatment within five months of their first release.

The pre-print study, which has yet to undergo peer review, concluded that those discharged from hospitals after receiving treatment for Covid-19 “face elevated rates of multiorgan dysfunction” and frequently require re-hospitalization, citing nearly 50,000 English patients reviewed in the research.

“Of 47,780 individuals in hospital with Covid-19 over the study period, 29.4 percent were readmitted and 12.3 percent died following discharge,” the paper said, with its authors noting that it is the largest study of its kind to date.

While much about what’s been dubbed “long Covid” or “Post Covid Syndrome” [PCS] – a condition in which symptoms of the virus, sometimes atypical ones, linger for months – remains unknown, a growing body of evidence suggests a large proportion of patients suffer symptoms well beyond their initial infection. Figures provided by the UK’s Office for

National Statistics, for example, indicate that up to one-fifth of England’s coronavirus patients still experience symptoms five weeks after contracting the illness, while half of that number experience them for at least 12 weeks.

Studies on American military veterans showed that some 20 percent of those with Covid-19 had to return to hospital for treatment within 60 days of discharge, while nine percent died. Citing that research, the authors of the UK-based study said that Covid-19 was found to be “associated with increased odds of acute kidney injury, renal replacement therapy, insulin use, pulmonary embolism, stroke, myocarditis, arrhythmia, and elevated troponin.”